Atlas Trials

Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

Clinical trial NCT04384653 · COMPLETED

Trial details

NCT number
NCT04384653
Sponsor
SQ Innovation, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Heart Failure
Start date
2020-10-17
Primary completion
2021-06-12
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.